Ethyne

Ethyne

SCHEMBL992878

C#C.[Li][Si](C)(C)C

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL116740 0.87
Ethyne SCHEMBL7907470 0.72
SCHEMBL31402443 0.67
SCHEMBL31463359 0.61
SCHEMBL509151 0.58
SCHEMBL687144 0.58
Ethyne SCHEMBL10836712 0.58
SCHEMBL8897699 0.54 ALDH1A1 (0.30)
Ethyne SCHEMBL6050547 0.53
SCHEMBL2184 0.53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118359532-A Method for synthesizing fluorine-containing substituted aza-aryl tertiary alcohol by using asymmetric olefin difunctional one-pot method under catalysis of chiral phosphoric acid 浙江工业大学 2024-07-19 CN claimed
CN-117777179-A Synthesis process of hexakis (trimethylsilyl ethynyl) benzene 山东大学 2024-03-29 CN claimed
CN-117003632-A Method for preparing 5-bromo-4, 5-tetrafluorovaleric acid 上海恩氟佳科技有限公司 2023-11-07 CN claimed
WO-2021103795-A1 OXIDIZED RING BELT [8] AROMATIC HYDROCARBON DERIVATIVE AND PREPARATION METHOD THEREFOR 清华大学 2021-06-03 WO claimed
CN-109280220-B Modified attapulgite, preparation method thereof and application of modified attapulgite in low-smoke halogen-free flame-retardant cable 江苏宝源高新电工有限公司 2020-05-12 CN claimed
CN-103059034-B Methods for synthesizing securinine natural products flueggine A, norsecurinine, virosaine B and allonorsecurinine UNIV PEKING SHENZHEN GRAD SCHO 2015-03-25 CN claimed
CN-103059034-A Methods for synthesizing securinine natural products flueggine A, norsecurinine, virosaine B and allonorsecurinine UNIV PEKING SHENZHEN GRAD SCHO 2013-04-24 CN claimed
US-12331036-B2 Heterocyclic RIP1 kinase inhibitors RIGEL PHARMACEUTICALS, INC. (US) 2025-06-17 US disclosed
EP-4025572-B1 HETEROCYCLIC RIP1 KINASE INHIBITORS RIGEL PHARMACEUTICALS INC (US) 2025-05-07 EP disclosed
EP-4025574-B1 RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME RIGEL PHARMACEUTICALS INC (US) 2025-05-07 EP disclosed
US-12156880-B2 Heterocyclic RIP1 kinase inhibitors RIGEL PHARMACEUTICALS, INC. (US) 2024-12-03 US disclosed
US-20240368119-A1 RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME RIGEL PHARMACEUTICALS, INC. 2024-11-07 US disclosed
CN-115397824-B Process for preparing COT inhibitor compounds 吉利德科学公司 2024-10-22 CN disclosed
CN-101309586-A Thiazole compounds as fungicides BAYER CROPSCIENCE AG (DE) 2008-11-19 CN disclosed
CN-100402497-C Fluorinated vitamin D3 analogs HOFFMANN LA ROCHE (CH) 2008-07-16 CN disclosed
EP-1490060-A1 ANTIDIABETIC AGENTS WARNER-LAMBERT COMPANY LLC (US) 2004-12-29 EP disclosed
US-6696474-B2 SUCH AS 8-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-2-PYRROL-1-YL-OCT-4-YNOIC ACID; NONINSULIN DEPENDENT DIABETES MELLITUS WARNER LAMBERT CO. LLC. 2004-02-24 US disclosed
US-20030220381-A1 ANTIDIABETIC AGENTS WARNER-LAMBERT COMPANY, LLC 2003-11-27 US disclosed
WO-2003082276-A1 ANTIDIABETIC AGENTS WARNER-LAMBERT COMPANY LLC (US) 2003-10-09 WO disclosed
CN-1172801-A Fluorinated vitamin D3 analogs HOFFMANN LA ROCHE (CH) 1998-02-11 CN disclosed